#AATADPD

1 stories · following the connections

Business

Cognition Therapeutics Presenting Evidence for Elayta Synaptic Protection in Alzheimer’s Patients at Combined AAT-AD/PD Focus Meeting

By Nasdaq OMXMar 14, 2018, 2:33 PM UTC